Acyclic nucleoside phosphonates containing a second phosphonate group are potent inhibitors of the 6-oxopurine phosphoribosyltransferases and have antimalarial activity
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1475-2875
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Acyclic nucleoside phosphonates containing a second phosphonate group are potent inhibitors of the 6-oxopurine phosphoribosyltransferases and have antimalarial activity ; volume:13 ; number:1 ; day:22 ; month:9 ; year:2014 ; pages:1-2 ; date:9.2014
Malaria journal ; 13, Heft 1 (22.9.2014), 1-2, 9.2014
- Urheber
-
Keough, Dianne
- Beteiligte Personen und Organisationen
-
Špaček, Petr
Hocková, Dana
Tichý, Tomáš
Vrbková, Silvie
Slavětínská, Lenka
Janeba, Zlatko
Naesens, Lieve
Edstein, Michael
Chavchich, Marina
Wang, Tzu
de Jersey, John
Guddat, Luke
SpringerLink (Online service)
- DOI
-
10.1186/1475-2875-13-S1-P91
- URN
-
urn:nbn:de:1111-2016080649534
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
- 14.08.2025, 10:51 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Keough, Dianne
- Špaček, Petr
- Hocková, Dana
- Tichý, Tomáš
- Vrbková, Silvie
- Slavětínská, Lenka
- Janeba, Zlatko
- Naesens, Lieve
- Edstein, Michael
- Chavchich, Marina
- Wang, Tzu
- de Jersey, John
- Guddat, Luke
- SpringerLink (Online service)
Ähnliche Objekte (12)
Acyclic nucleoside phosphonates containing the amide bond
Synthesis of some novel hydrazono acyclic nucleoside analogues
Acyclic nucleoside phosphonates containing the amide bond: hydroxy derivatives
Novel acyclic nucleoside analogues as inhibitors of HIV-1 RT
In-silico designing of acyclic nucleoside phosphonates and their anti-HIV potential
N2′‐Branched Acyclic Nucleoside Phosphonates Containing 9‐Deazahypoxanthine as Inhibitors of Plasmodium falciparum 6‐Oxopurine Phosphoribosyltransferase
Selecting an anti-malarial clinical candidate from two potent dihydroisoquinolones
Acyclic organonitrogen stereodynamics
Totally Acyclic Complexes
Retargeting azithromycin analogues to have dual-modality antimalarial activity
Substrate Peptidomimetic Inhibitors of P. falciparum Plasmepsin X with Potent Antimalarial Activity
Synthese carbocyclischer Nucleoside
Acyclic nucleoside phosphonates containing the amide bond
Synthesis of some novel hydrazono acyclic nucleoside analogues
Acyclic nucleoside phosphonates containing the amide bond: hydroxy derivatives
Novel acyclic nucleoside analogues as inhibitors of HIV-1 RT
In-silico designing of acyclic nucleoside phosphonates and their anti-HIV potential
N2′‐Branched Acyclic Nucleoside Phosphonates Containing 9‐Deazahypoxanthine as Inhibitors of Plasmodium falciparum 6‐Oxopurine Phosphoribosyltransferase
Selecting an anti-malarial clinical candidate from two potent dihydroisoquinolones
Acyclic organonitrogen stereodynamics
Totally Acyclic Complexes
Retargeting azithromycin analogues to have dual-modality antimalarial activity
Substrate Peptidomimetic Inhibitors of P. falciparum Plasmepsin X with Potent Antimalarial Activity
Synthese carbocyclischer Nucleoside
Acyclic nucleoside phosphonates containing the amide bond
Synthesis of some novel hydrazono acyclic nucleoside analogues
Acyclic nucleoside phosphonates containing the amide bond: hydroxy derivatives
Novel acyclic nucleoside analogues as inhibitors of HIV-1 RT
In-silico designing of acyclic nucleoside phosphonates and their anti-HIV potential
N2′‐Branched Acyclic Nucleoside Phosphonates Containing 9‐Deazahypoxanthine as Inhibitors of Plasmodium falciparum 6‐Oxopurine Phosphoribosyltransferase
Selecting an anti-malarial clinical candidate from two potent dihydroisoquinolones
Acyclic organonitrogen stereodynamics
Totally Acyclic Complexes
Retargeting azithromycin analogues to have dual-modality antimalarial activity
Substrate Peptidomimetic Inhibitors of P. falciparum Plasmepsin X with Potent Antimalarial Activity